References
- Herr HW. Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy. Urology 1985; 25: 127–34
- Widmark A, Flodgren P, Damber JE, Hellsten S, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in urinary bladder cancer. Acta Oncol 2003; 42: 567–81
- Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC. Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients. Cancer 1994; 74: 2819–27
- Granfors T, Duchek M, Tomic R, Roos G, Ljungberg B. Predictive value of DNA ploidy in bladder cancer treated with preoperative radiation therapy and cystectomy. Scand J Urol Nephrol 1996; 30: 281–5
- Smith JA, Jr, Crawford ED, Paradelo JC, Blumenstein B, Herschman BR, Grossman HB, Christie DW. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study. J Urol 1997; 157: 805–7
- Sengelöv L, von der Maase H. Radiotherapy in bladder cancer. Radiother Oncol 1999; 52: 1–14
- Sherif A, Holmberg L, Rintala E, Mestad O, Nilsson J, Nilsson S, et al. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies. Eur Urol 2004; 45: 297–303
- Rodel C, Weiss C, Sauer R. Organ preservation by combined modality treatment in bladder cancer: the European perspective. Semin Radiat Oncol 2005; 15: 28–35
- Shipley WU, Zietman AL, Kaufman DS, Coen JJ, Sandler HM. Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates – the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol 2005; 15: 36–41
- Fosså SD, Ous S, Berner A. Clinical significance of the “palpable mass” in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy. Br J Urol 1991; 67: 54–60
- Soloway MS, Lopez AE, Patel J, Lu Y. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 1994; 73: 1926–31
- Wijkström H, Norming U, Lagerkvist M, Nilsson B, Näslund I, Wiklund P. Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients. Br J Urol 1998; 81: 686–91
- Ghoneim MA, Ashamallah AK, Awaad HK, Whitmore WF, Jr. Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. J Urol 1985; 134: 266–8
- Parsons JT, Million RR. Planned preoperative irradiation in the management of clinical stage B2-C (T3) bladder carcinoma. Int J Radiat Oncol Biol Phys 1988; 14: 797–810
- Malmström PU, Rintala E, Wahlqvist R, Hellström P, Hellsten S, Hannisdal E. Five-year follow-up of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group. J Urol 1996; 155: 1903–6
- Tomic R, Granfors T, Modig H. Morbidity after preoperative radiotherapy and cystectomy in patients with bladder cancer. Scand J Urol Nephrol 1997; 31: 149–53
- Jahnson S, Pedersen J. Cystectomy and urinary diversion during twenty years – complications and metabolic implications. Eur Urol 1993; 24: 343–9
- Hautmann RE, Gschwend JE, de Petriconi RC, Kron M, Volkmer BG. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 2006; 176: 486–92
- Dhar NB, Campbell SC, Zippe CD, Derweesh IH, Reuther AM, Fergany A, Klein EA. Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection. BJU Int 2006; 98: 1172–5
- Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006; 176: 2414–22